No Data
Earnings Are Growing at Shenzhen Lifotronic Technology (SHSE:688389) but Shareholders Still Don't Like Its Prospects
Shenzhen Lifotronic Technology Co., Ltd. (688389.SH): There is currently no revenue from the USA market in international income.
On December 10, Gelonghui reported that shenzhen lifotronic technology co., ltd. (688389.SH) stated on the interactive platform that in the first three quarters of 2024, the company's international business revenue accounted for 29.52% of the total revenue, and there is currently no revenue from the usa market in the international revenue.
Shenzhen Lifotronic Technology Gets Medical Device Registration for Spectral Therapeutic Device; Shares Down 7%
Recent 6.6% Pullback Would Hurt Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Insiders
shenzhen lifotronic technology co., ltd. (688389.SH): International markets are expected to have higher expectations for mid-speed luminescence instruments.
Gelonghui November 8th | Shenzhen Lifotronic Technology Co., Ltd. (688389.SH) stated during a specific target investigation that the company's large fluorescent products are mainly marketed to public hospitals in the international market. The market characteristics vary among different countries, with some countries having government-led procurement for laboratories, preferring large equipment, while some medical institutions in other countries tend to choose medium-speed models. For most countries, due to population constraints, there is not high demand for large fluorescent and assembly line products. Medium-speed fluorescent instruments can meet the tender requirements of many overseas public hospitals, and the company's research and development of medium-speed fluorescent instruments can expand the market along with small fluorescent instruments.
Pumen Technology: Shenzhen Pumen Technology Co., Ltd. 2024 Third Quarter Report
Insufficient Growth At Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Hampers Share Price
